[{"id":"mckesson-us-oncology","kind":"company","name":"McKesson / The US Oncology Network","route":"/companies/mckesson-us-oncology/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.usoncology.com\" }]"}]},{"id":"mckesson-us-oncology","kind":"company","name":"McKesson / The US Oncology Network","route":"/companies/mckesson-us-oncology/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"tldr","before":"\"Largest US community oncology network (about 3,000 providers) and drug distributor; co-owner of Sarah Cannon Research Institute.\"","after":"\"McKesson runs the largest US community oncology network (about 3,000 providers) and distributes drugs, and co-owns the Sarah Cannon Research Institute.\""}]},{"id":"mckesson-us-oncology","kind":"company","name":"McKesson / The US Oncology Network","route":"/companies/mckesson-us-oncology/","commit":"6d26880f6f","date":"2026-09-08","author":"Jude Gomila","message":"Add supporting technologies, infrastructure companies, and regulatory-science terms","file":"src/data/supporting.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"hq"},{"field":"country"},{"field":"companyType"},{"field":"website"},{"field":"ticker"},{"field":"sections"},{"field":"tldr"},{"field":"summary"},{"field":"technologies"}]}]